Patients With Psoriasis Who Are Treated With Biologics May Have Higher Risk For HBV And HCV Reactivations, Study Indicates

February 07, 2020

Dermatology Advisor (2/6, May) reports researchers found that “patients with psoriasis who are treated with biologics have a higher risk for hepatitis B virus (HBV) and hepatitis C virus (HCV) reactivations, especially if they are young, hepatitis B surfa...